STOCK TITAN

Cognizant Named a Leader in Life Sciences Digital Services by Independent Analyst Firm Everest Group

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Cognizant (NASDAQ: CTSH) has been recognized as a Leader in the Life Sciences Digital Services Peak Matrix® Assessment 2022 by Everest Group. This accolade emphasizes Cognizant's domain expertise and expanding portfolio in life sciences, particularly in medical device enhancements and clinical trials. The assessment reviewed 31 global digital providers, highlighting Cognizant's partnerships with notable firms like Philips and Medidata, alongside its strategic acquisitions such as TQS and Zenith. The company's innovative solutions like OneCare and Neuro are also acknowledged for meeting industry needs.

Positive
  • Named a Leader by Everest Group in Life Sciences Digital Services, reflecting strong domain expertise.
  • Strategic partnerships with Philips, Benchling, and Medidata enhance service offerings.
  • Acquisitions of TQS and Zenith position Cognizant as a leader in the Life Sciences Industry 4.0 space.
  • Innovative solutions like OneCare and Neuro address emerging industry needs.
Negative
  • None.

Report Highlights Cognizant's Partnerships, Acquisitions and Talent Investment as Keys to Delivering Expertise, Offerings, and Success for Clients

TEANECK, N.J., Nov. 23, 2022 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) was recently named a Leader by Everest Group in its Life Sciences Digital Services Peak Matrix ® Assessment 2022. The analyst firm highlighted Cognizant's domain expertise and growing portfolio of life sciences digital services to support the industry's increasing focus on medical device enhancements, commercial life cycles, and clinical trials.

"The last few years have shown the importance of integrating technology with life sciences to speed the development of vaccines, improve cybersecurity, and enhance innovation," said Surya Gummadi, Cognizant's Global Head of Health Sciences. "Everest Group's recognition of Cognizant's leadership in this field highlights the investments this company is making to partner on and build out the solutions of tomorrow that our clients need to address market trends, comply with regulatory requirements, and accelerate therapeutic discoveries."

The report evaluated 31 leading life sciences digital providers from across the globe on their client case studies, expanding capabilities, investments, and solutions offerings. Everest Group determined Cognizant's leadership by its domain expertise, and its well-balanced portfolio supported by various partnerships, including Philips, Benchling, and Medidata. Cognizant's acquisitions of TQS and Zenith were also highlighted in the report as having positioned the company as a leader in the life sciences Industry 4.0 space, while Cognizant's new solutions, including OneCare and Neuro, were lauded for addressing rapidly emerging industry needs, such as digital twin technology and robotic process automation.

"Cognizant's leadership, driven by its vision, expertise and capabilities, has helped its clients enhance their race to comply with a changing market, from the use of artificial intelligence and machine learning to support drug discovery to digital twin technology that supports supply chain management," said Alisha Mittal, Vice President, Everest Group. "Numerous case studies, expanding services, and a comprehensive network of partners and M&A have helped position Cognizant as a company successfully supporting the fast-changing life sciences market."

Learn more: Cognizant's Health Sciences Practice

About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at www.cognizant.com or @cognizant.

For more information, contact:

U.S.

Josh Blumenthal

Joshua.Blumenthal@Cognizant.com  


Europe / APAC

Christina Schneider

Christina.Schneider@Cognizant.com


India

Rashmi Vasisht

Rashmi.Vasisht@Cognizant.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cognizant-named-a-leader-in-life-sciences-digital-services-by-independent-analyst-firm-everest-group-301685663.html

SOURCE Cognizant

FAQ

What recognition did Cognizant receive from Everest Group?

Cognizant was named a Leader in the Life Sciences Digital Services Peak Matrix® Assessment 2022.

What partnerships does Cognizant have in the life sciences sector?

Cognizant has partnerships with Philips, Benchling, and Medidata.

What acquisitions has Cognizant made to enhance its offerings?

Cognizant acquired TQS and Zenith to bolster its capabilities in life sciences.

What innovative solutions has Cognizant introduced recently?

Cognizant has introduced solutions like OneCare and Neuro to address industry needs.

What does Everest Group's report say about Cognizant's capabilities?

The report highlights Cognizant's domain expertise and well-balanced portfolio of life sciences digital services.

Cognizant Technology Solutions

NASDAQ:CTSH

CTSH Rankings

CTSH Latest News

CTSH Stock Data

39.15B
494.98M
0.17%
99.6%
3.24%
Information Technology Services
Services-computer Programming Services
Link
United States of America
TEANECK